Truist Securities Maintains Buy on BKV, Raises Price Target to $34
Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and raises the price target from $33 to $34.
Stocks · News reference
BKV Q2 2026 Earnings Call Transcript
BKV (NYSE:BKV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why Is BKV Stock Surging Wednesday?
BKV stock rises after securing a power equipment deal backed by a major hyperscaler for a 1,200 MW Texas project.
Nasdaq Falls Over 100 Points; US Crude Inventories Decline
U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciences